Adding ENDRA Life Sciences (NDRA) $0.89 to Watch List.
Another Fatty Liver Idea. This Time a Play on Detecting Fatty Liver Non-Invasively. Heads Up. Nearing Resistance at $0.89.
Video: Okay, You Tested Positive for Corona, Now What?
https://youtu.be/vN30emwcNS4
Professor Roger Seheult,...
News, As Huge As It Gets, From Hepion Pharma (HEPA) $2.10.
Of course, approval news is the ultimate "as huge as it gets" news.
But at this stage...
A Medical Technology That Has The Highest Potential Over Any We Follow.
You Must Read This...
New Report on the People Behind EMulate Therapeutics.
200 Million...
OTC Markets Group Welcomes Direct Communication Solutions (DCSX), Inc. to OTCQX
NEW YORK, Dec. 16, 2020
NEW YORK, Dec. 16, 2020 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for...
Alpine 4 Stock Surges After Impossible Aerospace Acquisition and DJI Blacklist
Alpine 4 Technologies Ltd. (OTCMKTS:ALPP) stock had risen 1,900% in 4 weeks as of December 15. The stock price isn’t high –...
Is The Market Overvalued? Barron’s Round Table January 2000.
Interesting viewpoints ahead of the market drifting from near 12,000 to 7,000. Equivalent to Dow dropping to near 20,000 today.
Remember President Trump Taking Dexamethasone? Hepion’s (HEPA) CRV431 demonstrated reduced lung inflammation and damage...
Hepion (HEPA) Announces FDA Clearance of IND Application for CRV431 for COVID-19
And Slowly But Surely..We Have Another 10-Bagger. PetVivo (PETV).
Things moving rather swimmingly at Pet-Vivo (PETV). Well, chart-wise.
REWARDS GO TO THE PATIENT?
Jim Kwik and Kevin Harrington Join Hapbee Technologies (HAPB) Board.
Hapbee Announces Additions to Advisory Board
December 17, 2020
New Advisors Bring Decades of Entrepreneurial ExperienceWellness...
Latest article
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
GeoVax (GOVX) Launches Vaccine Manufacturing System.
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
Manufacturing Process for Phase 3 and Commercial Production...
